| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/17/2008 | CN101264173A Pharmaceutical formulation for treating tuberculosis and preparation process |
| 09/17/2008 | CN101264156A Externally-applied medicament for treating shingles |
| 09/17/2008 | CN101264138A Method for processing calculus bovis bacteriostatic lotion |
| 09/17/2008 | CN101264136A Chinese medicine preparation for treating wind-heat type common cold and preparation thereof |
| 09/17/2008 | CN101264135A Biological sterilization preparations |
| 09/17/2008 | CN101264127A Sophora alopecuroids total alkaloid powder injection and preparation thereof |
| 09/17/2008 | CN101264118A Preparation of cirsium japonicum root powder preparation and uses thereof |
| 09/17/2008 | CN101264109A Medicinal composition for preventing and controlling pig diarrhea |
| 09/17/2008 | CN101264098A Medicinal composition for preventing and controlling livestock and fowls from infection disease |
| 09/17/2008 | CN101264089A Fusidate sodium composition and preparation of its freeze-drying preparations |
| 09/17/2008 | CN101264088A Antibiotics composition with stable content and rapid solubility |
| 09/17/2008 | CN101264087A Medicinal composition containing cefpodoxime proxetil cyclodextrin inclusion compound and preparation thereof |
| 09/17/2008 | CN101264086A Medicinal composition containing cefixime cyclodextrin inclusion compound and preparation thereof |
| 09/17/2008 | CN101264085A Medicinal composition containing cefdinir cyclodextrin inclusion compound and preparation thereof |
| 09/17/2008 | CN101264080A Pharmaceutical composition containing dexchlorpheniramine and preparation thereof |
| 09/17/2008 | CN101264079A Oxymatrine nano preparations for liver cell targeting injection and preparation thereof |
| 09/17/2008 | CN101264078A Jiabing sustained-release film and preparation thereof |
| 09/17/2008 | CN101264069A Application of resveratrol derivative in preparing medicine for treating disease relative to immune |
| 09/17/2008 | CN101264067A Florfenicol capsule for silkworm |
| 09/17/2008 | CN101264054A Rifamycin sodium injection and preparation thereof |
| 09/17/2008 | CN101264051A Modified release pharmaceutical formulation |
| 09/17/2008 | CN101263812A Sterilization disinfectant and preparation |
| 09/17/2008 | CN100419073C Live vaccine for mycoplasma pneumonia of swine and production method thereof |
| 09/17/2008 | CN100418980C Process for purifying glycopeptide phospohonate derivatives |
| 09/17/2008 | CN100418972C Cephe alkene onium salt compound and its preparation and use in preparation of cefepime |
| 09/17/2008 | CN100418955C Novel Benzo-fused heterocycles |
| 09/17/2008 | CN100418576C Subcutaneously-administered ganglioside-based vaccine compositions |
| 09/17/2008 | CN100418565C Chinese herbal liquor for treating manus tenea, pedes tenea, onychomycosis and its preparation process |
| 09/17/2008 | CN100418537C Amphotericin B slow-releasing microsphere, and its prepn. method |
| 09/17/2008 | CN100418536C Ophthalmic pharmaceutical composition for resisting fungus |
| 09/17/2008 | CN100418532C Use of NF-kB inhibitor for treating several diseases |
| 09/17/2008 | CN100418530C Ketoconazole eye drops and fabricating method thereof |
| 09/17/2008 | CN100418527C Improved pharmaceutical formulations |
| 09/17/2008 | CN100418506C Anti-germ attachment composition |
| 09/17/2008 | CN100418430C Biological health tea |
| 09/16/2008 | US7425606 Identifying cryptic epitopes comprising amino acid sequences of tumor antigen for diagnosis and treatment of viral and cancer disorder; viricides; antitumor agents |
| 09/16/2008 | US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425547 Nucleoside derivatives for treating hepatitis C virus infection |
| 09/16/2008 | US7425449 Site specific Listeria integration vectors and methods for using the same |
| 09/16/2008 | US7425337 Alphavirus replicon vector systems |
| 09/16/2008 | US7425335 Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus |
| 09/16/2008 | US7425327 Choline binding proteins for anti-pneumococcal vaccines |
| 09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
| 09/16/2008 | US7425292 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 09/16/2008 | CA2623858A1 Stabilized chlorine dioxide and hypochlorous acid in a liquid biocide |
| 09/16/2008 | CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor |
| 09/16/2008 | CA2467801C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/16/2008 | CA2378503C Manufacture and use of an antibiotic/antibiotics(or: antibiotic(s)) preparation |
| 09/16/2008 | CA2378483C Crystalline 1-methylcarbapenem compounds |
| 09/16/2008 | CA2223910C Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 09/16/2008 | CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist |
| 09/16/2008 | CA2102301C Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 09/12/2008 | WO2008109837A2 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell |
| 09/12/2008 | WO2008109584A1 Hcv ns5b inhibitors |
| 09/12/2008 | WO2008109401A2 Composition and method for treating papilloma virus and equine sarcoids |
| 09/12/2008 | WO2008108988A1 Antimicrobial heterocyclic compounds for treatment of bacterial infections |
| 09/12/2008 | WO2008108918A1 Human antibodies against hepatitis c virus (hcv) uses thereof |
| 09/12/2008 | WO2008108630A1 Polymorphic forms of efavirenz |
| 09/12/2008 | WO2008108323A1 Drug for treatment of influenza |
| 09/12/2008 | WO2008107641A1 Liposome preparation |
| 09/12/2008 | WO2008107187A1 Antibodies specific for rubella virus |
| 09/12/2008 | WO2008106980A2 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 09/12/2008 | WO2008106979A2 Pharmaceutical compositions comprising flavonoids and xylitol |
| 09/12/2008 | WO2008106803A1 Double-stranded locked nucleic acid compositions |
| 09/12/2008 | WO2008106763A1 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| 09/12/2008 | WO2008106715A1 Oxazinyl isoflavonoid compounds, medicaments and use |
| 09/12/2008 | WO2008089569A9 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 09/12/2008 | WO2008089105A3 Antiviral nucleoside analogs |
| 09/12/2008 | WO2007089945A3 Treating diseases by targeting silt3 |
| 09/12/2008 | CA2680415A1 Neuraminic acid derivatives useful in the treatment of influenza |
| 09/12/2008 | CA2680129A1 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell |
| 09/12/2008 | CA2680060A1 Double-stranded locked nucleic acid compositions |
| 09/12/2008 | CA2680038A1 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| 09/12/2008 | CA2679743A1 Methods and compositions involving polymeric immunoglobulin fusion proteins |
| 09/12/2008 | CA2679657A1 Antimicrobial heterocyclic compounds for treatment of bacterial infections |
| 09/12/2008 | CA2679580A1 Oxazinyl isoflavonoid compounds, medicaments and use |
| 09/12/2008 | CA2678888A1 Human antibodies against hepatitis c virus (hcv) and uses thereof |
| 09/12/2008 | CA2678628A1 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 09/12/2008 | CA2661896A1 Specific lysis of staphylococcal pathogens by bacteriophage phi1 1 endolysin |
| 09/11/2008 | US20080221215 Antiviral inhibition of capsid proteins |
| 09/11/2008 | US20080221191 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens |
| 09/11/2008 | US20080221190 fungicides; good yields; steps require neither solvents nor reactants that are highly flammable and explosive, carcinogenic or corrosive; 1-chloro-4-chlorophenyl-2-butanol is reacted with the imidazole in toluene and aqueous sodium hydroxide solution in the presence of a phase transfer catalyst |
| 09/11/2008 | US20080221183 Anti-cancer and anti-microbial oxazolidinones |
| 09/11/2008 | US20080221180 Thiazole Derivatives and Use Thereof |
| 09/11/2008 | US20080221159 Inhibitors of human immunodeficiency virus replication |
| 09/11/2008 | US20080221158 Novel 14 and 15 Membered Ring Compounds |
| 09/11/2008 | US20080221154 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 09/11/2008 | US20080221142 useful in interfering with the life cycle of bacteria and in treating or preventing a bacterial infection |
| 09/11/2008 | US20080221140 reverse transcriptase mutants which allow an obligate chain terminating nucleoside- or nucleotide phosphate to be excised from the nascent DNA strand by ATP- or pyrophosphate-mediated excision |
| 09/11/2008 | US20080221110 Tricyclic condensed ring nitrogen compound selectively acts on cannabinoid receptors; Gram-negative and Gram-positive bacterial infections; 1-({4-[(6,7-Dihydro[1,4]dioxino[2,3-c]pyridazin-3-ylmethyl)amino]-1-piperidinyl}methyl)-9-fluoro-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one |
| 09/11/2008 | US20080221102 Composition and methods for modulating a kinase cascade |
| 09/11/2008 | US20080221099 Dihydropteridinones for the treatment of cancer diseases |
| 09/11/2008 | US20080221090 treating hepatitis C infection; 6-cyclohexyl-2,3-dihydro-5-phenyl-1,4-oxazino[2,3,4-hi]indole-9-carboxylic acid |
| 09/11/2008 | US20080221086 Novel Inhibitors of Glutaminyl Cyclase |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080221076 Crystalline Sodium Salt of Cephalosporin Antibiotic |
| 09/11/2008 | US20080221069 Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders |